Table 1 Baseline characteristics of the study population
|  | n (%), Total n = 41 |
|---|---|
Demographics | |
 Age | 52 ± 11 |
 BMI, kg/m2 | 26.8 ± 6.3 |
Cardiovascular risk factors | |
 Hypertension | 10 (24.4%) |
 Diabetes | 4 (9.8%) |
 Hypercholesterolemia | 3 (7.3%) |
 Coronary artery disease | 1 (2.4%) |
 Smoking | 10 (24.4%) |
 Medications: | |
  Beta-blocker | 3 (9%) |
  ACE inhibitor | 3 (9%) |
  NYHA class III/IV | 0 |
Cancer-related variables | |
 Breast cancer site | |
  Left | 27 (65.9%) |
Stage of disease | |
 Early | 27 (68%) |
 Locally invasive | 13 (32%) |
Type of surgery | |
 Breast-conserving surgery | 22 (53.7%) |
 Mastectomy | 19 (46.3%) |
Chemotherapeutic regimen | |
 Anthracycline based | 23 (56.1%) |
 Left sided radiation | 12 (29.3) |
Biomarkers: | |
 High sensitivity-troponin I, ng/mL (n = 37)a | <0.006 (<0.006–0.012) |
 NT-BNP, ng/mL (n = 39)a | 57 (33–128) |
 LV parameters |  |
  LVEDV, ml | 129.7 ± 24.9 |
  LVESV, ml | 51.5 ± 12 |
 LVEF, % | 60.4 ± 4.2 |
 RV parameters |  |
  RVEDV, ml | 121 ± 24 |
  RVESV, ml | 51 ± 11 |
  RVEF, % | 58.3 ± 3.8 |